How does myelin injury change nerve signaling?

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. Myelin wraps around axons and helps electrical signals travel efficiently. When myelin is injured, signaling can slow or become temporarily blocked. Depending on the site involved, a person may notice altered vision, tingling, weakness, or balance difficulty. Symptoms and recovery vary with lesion location and extent, the timing of inflammation, and the degree of repair or remyelination. The number of spots seen on a scan does not map one-to-one to how disabled a person feels in daily life.

The immune process is not a single-cell chain

MS lesions involve immune cells entering from the blood as well as resident cells such as microglia and astrocytes in the CNS. Interactions among T cells, B cells, inflammatory mediators, oxidative stress, and altered energy balance can affect oligodendrocytes, which make myelin, and the axons they insulate. It is therefore too definite to say that one T-cell type recognizing one myelin antigen causes the same sequence in every person. As inflammation changes, partial remyelination may help restore signaling, but repair can be incomplete and axonal injury can accumulate. The balance between damage and recovery differs across people and over the course of disease.

Imaging and test results need clinical context

The McDonald diagnostic criteria were revised in 2024 and published in 2025. The revision adds the optic nerve as a fifth CNS location considered in diagnosis and describes supportive evidence such as the central vein sign, paramagnetic rim lesions, and cerebrospinal-fluid kappa free-light-chain concentrations in specific situations. This does not mean that one MRI phrase or laboratory result diagnoses MS by itself. Neurologists combine the symptom history and examination with lesion location and pattern, change over time, and, when indicated, cerebrospinal-fluid and other test results. They also consider whether another condition—such as infection, vascular disease, or another inflammatory demyelinating disorder—better explains the findings. Age and other health conditions can affect interpretation. A criteria list is not a self-diagnosis tool.

A practical way to prepare for a neurology visit

Imagine a person who had pain and blurred vision in one eye for several days and later noticed tingling. They could write down when each change began, how long it lasted, whether it appeared suddenly or gradually, and whether it improved or returned. For a vision change, note whether one or both eyes seemed affected and what looked different, without assigning a diagnosis. Record a fever, infection, heat exposure, other conditions, or medication changes that overlapped with symptoms; these details may help the clinician consider alternatives or symptom fluctuation. Bring dates and reports for prior MRI, visual evoked potential, optical coherence tomography, or spinal-fluid testing if available. Questions might include: “Does this finding match the location of my symptom?” and “What other explanations need to be considered?” This is a visit-preparation example, not a checklist for diagnosing MS.

Treatment decisions are individualized

Disease-modifying and symptom-focused treatments are discussed with a specialist in light of disease activity and course, other health conditions, pregnancy plans, infection and safety risks, and the person’s preferences. A diagnostic-criteria paper does not establish that one drug or treatment strategy is best. If you already receive treatment, do not stop or change it on your own because of a new symptom or concern; contact the prescribing team for advice. Sudden loss of vision, new major weakness, or difficulty walking can require prompt assessment. This article is general education, not diagnosis or a prescription.

Sources